| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered Bone Biology in Psoriatic Arthritis
|
Rahimi, Homaira
|
|
2012
|
14 |
4 |
p. 349-357
|
artikel
|
| 2 |
Belimumab and the Clinical Data
|
Shum, Katrina
|
|
2012
|
14 |
4 |
p. 310-317
|
artikel
|
| 3 |
Belimumab Is Approved by the FDA: What More Do We Need to Know to Optimize Decision Making?
|
Horowitz, Diane Lewis
|
|
2012
|
14 |
4 |
p. 318-323
|
artikel
|
| 4 |
Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?
|
Stohl, William
|
|
2012
|
14 |
4 |
p. 303-309
|
artikel
|
| 5 |
Cardiovascular Mortality in Psoriasis and Psoriatic Arthritis: Epidemiology, Pathomechanisms, Therapeutic Implications, and Perspectives
|
Boehncke, Wolf-Henning
|
|
2012
|
14 |
4 |
p. 343-348
|
artikel
|
| 6 |
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
|
Pike, Marilyn C.
|
|
2012
|
14 |
4 |
p. 324-333
|
artikel
|
| 7 |
How Can Psoriatic Arthritis Be Diagnosed Early?
|
Haddad, Amir
|
|
2012
|
14 |
4 |
p. 358-363
|
artikel
|
| 8 |
Impact of Psoriatic Arthritis on the Patient: Through the Lens of the WHO International Classification of Functioning, Health, and Disability
|
Taylor, William J.
|
|
2012
|
14 |
4 |
p. 369-374
|
artikel
|
| 9 |
Is Psoriatic Arthritis a Result of Abnormalities in Acquired or Innate Immunity?
|
Lories, Rik J.
|
|
2012
|
14 |
4 |
p. 375-382
|
artikel
|
| 10 |
The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus
|
Davidson, Anne
|
|
2012
|
14 |
4 |
p. 295-302
|
artikel
|
| 11 |
Treatment Algorithms for Early Psoriatic Arthritis: Do They Depend on Disease Phenotype?
|
Tillett, William
|
|
2012
|
14 |
4 |
p. 334-342
|
artikel
|
| 12 |
What Have Genome-Wide Studies Told Us About Psoriatic Arthritis?
|
Bluett, James
|
|
2012
|
14 |
4 |
p. 364-368
|
artikel
|
Tijdschrift beschrijving